DEERFIELD MANAGEMENT COMPANY, L.P.
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 1009258
NEW YORK, NY
Position in BCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$150,964,030
+$7,802,270 QoQ
Shares Held
15,096,403
+0.4% QoQ
Ownership
5.91%
of shares outstanding
% of Portfolio
2.56%
of 13F equity value
Holder Rank
#4
of 316 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026DEERFIELD MANAGEMENT COMPANY, L.P. holds $870,646,189 across 5 Drug Manufacturers - Specialty & Generic names. BCRX ranks #3 (17.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
20,206,170 | $320,873,979 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
457,000 | $247,616,310 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
15,096,403 | $150,964,030 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
752,999 | $83,537,709 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,648,895 | $67,654,161 |
All Filings in BCRX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $150,964,030 | 15,096,403 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $143,161,760 | 15,038,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $111,859,800 | 14,341,000 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $92,362,710 | 12,169,000 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $42,040,320 | 4,692,000 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $38,922,487 | 5,189,665 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $61,246,203 | 8,144,442 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $61,832,110 | 8,135,804 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $50,279,268 | 8,135,804 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $25,374,600 | 4,995,000 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $27,191,754 | 4,539,525 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $23,264,880 | 3,286,000 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $9,306,880 | 1,322,000 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $23,060,100 | 2,765,000 | Shares | Defined | 2023-05-15 | |
| 2022-03-31 | $16,455,120 | 1,012,000 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $23,353,039 | 1,686,140 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,371,819 | 234,643 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $44,821,350 | 2,835,000 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $26,496,714 | 2,605,380 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $43,476,784 | 5,835,810 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $15,330,425 | 4,456,519 | Shares | Defined | 2020-12-30 | |
| 2020-06-30 | $21,213,030 | 4,456,519 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $9,305,852 | 4,652,926 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||